BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29137465)

  • 21. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of calcium-vitamin D supplementation on metabolic profiles in pregnant women at risk for pre-eclampsia: a randomized placebo-controlled trial.
    Asemi Z; Tabassi Z; Heidarzadeh Z; Khorammian H; Sabihi SS; Samimi M
    Pak J Biol Sci; 2012 Apr; 15(7):316-24. PubMed ID: 24163957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency.
    Ardabili HR; Gargari BP; Farzadi L
    Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome.
    Jamilian M; Shojaei A; Samimi M; Afshar Ebrahimi F; Aghadavod E; Karamali M; Taghizadeh M; Jamilian H; Alaeinasab S; Jafarnejad S; Asemi Z
    J Affect Disord; 2018 Mar; 229():41-47. PubMed ID: 29306057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of vitamin D, K and calcium co-supplementation on carotid intima-media thickness and metabolic status in overweight type 2 diabetic patients with CHD.
    Asemi Z; Raygan F; Bahmani F; Rezavandi Z; Talari HR; Rafiee M; Poladchang S; Darooghegi Mofrad M; Taheri S; Mohammadi AA; Esmaillzadeh A
    Br J Nutr; 2016 Jul; 116(2):286-93. PubMed ID: 27198036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of magnesium-zinc-calcium-vitamin D co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in gestational diabetes.
    Jamilian M; Mirhosseini N; Eslahi M; Bahmani F; Shokrpour M; Chamani M; Asemi Z
    BMC Pregnancy Childbirth; 2019 Mar; 19(1):107. PubMed ID: 30922259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review.
    Menichini D; Facchinetti F
    Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial.
    Karamali M; Heidarzadeh Z; Seifati SM; Samimi M; Tabassi Z; Hajijafari M; Asemi Z; Esmaillzadeh A
    J Diabetes Complications; 2015; 29(8):1314-9. PubMed ID: 26233572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
    J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S; Ahangari R; Hozoori M; Mozaffari-Khosravi H; Fallahzadeh H; Nadjarzadeh A
    J Endocrinol Invest; 2018 May; 41(5):597-607. PubMed ID: 29110281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.
    Raja-Khan N; Shah J; Stetter CM; Lott ME; Kunselman AR; Dodson WC; Legro RS
    Fertil Steril; 2014 Jun; 101(6):1740-6. PubMed ID: 24636395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
    Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of vitamin D and omega-3 fatty acid co-supplementation on glycemic control and lipid concentrations in patients with gestational diabetes.
    Jamilian M; Samimi M; Ebrahimi FA; Hashemi T; Taghizadeh M; Razavi M; Sanami M; Asemi Z
    J Clin Lipidol; 2017; 11(2):459-468. PubMed ID: 28502503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review.
    Li R; Li Z; Huang Y; Hu K; Ma B; Yang Y
    Front Endocrinol (Lausanne); 2022; 13():974042. PubMed ID: 35992132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Zarezade Mehrizi M; Foroozanfard F; Akbari H; Jamilian M; Ahmadi S; Asemi Z
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):560-566. PubMed ID: 27911471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes.
    Maktabi M; Jamilian M; Amirani E; Chamani M; Asemi Z
    Lipids Health Dis; 2018 Jul; 17(1):163. PubMed ID: 30025522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S
    Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.